Ownership history in BML Capital Management, LLC · 12 quarters on record
This page tracks every 13F SEC filing in which BML Capital Management, LLC reported a position in ORAMED PHARMACEUTICALS INC (ORMP). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 3,167,231 | — | 0% | 7.80% | $9.0M | $2.66 |
| 2025 Q3 | ADDED | 3,167,231 | +83,978 | +2.7% | 7.66% | $8.36B | $2.46 |
| 2025 Q2 | ADDED | 3,083,253 | +62,505 | +2.1% | 5.25% | $6.94B | $2.10 |
| 2025 Q1 | ADDED | 3,020,748 | +376,841 | +14.3% | 5.23% | $6.46B | $2.00 |
| 2024 Q4 | ADDED | 2,643,907 | +457,716 | +20.9% | 3.97% | $6.40B | $2.26 |
| 2024 Q3 | ADDED | 2,186,191 | +837,153 | +62.1% | 3.14% | $5.33B | $2.27 |
| 2024 Q2 | ADDED | 1,349,038 | +504,542 | +59.7% | 2.47% | $3.47B | $2.40 |
| 2024 Q1 | REDUCED | 844,496 | -417,063 | -33.1% | 1.65% | $2.47B | $2.72 |
| 2023 Q4 | ADDED | 1,261,559 | +480,267 | +61.5% | 2.22% | $2.91B | $2.15 |
| 2023 Q3 | REDUCED | 781,292 | -68,708 | -8.1% | 1.87% | $2.04B | $2.43 |
As of 2025 Q4 — sorted by position size